How to translate text using browser tools
10 March 2025 ELECTROCHEMOTHERAPY WITH CISPLATIN FOR THE TREATMENT OF A NON-OPERABLE ORAL SQUAMOUS CELL CARCINOMA IN A LOWLAND TAPIR (TAPIRUS TERRESTRIS)
Rúbia M. C. Cunha, Gleidice E. Lavalle, Roberto B. Araújo, Herlandes P. Tinoco, Carlyle M. Coelho, Fabíola de Oliveira Paes Leme, Anelise C. Nepomuceno, Luiz A. Lago, Daniel O. Santos, Renato L. Santos, Marcelo P. N. de Carvalho
Author Affiliations +
Abstract

Squamous cell carcinoma (SCC) is a malignant epidermal tumor. Biologic behavior and metastasis rate vary according to species and tumor location. The goal of this study was to report the occurrence and behavior of an oral SCC in a Tapirus terrestris treated with electrochemotherapy. The tapir was anesthetized for two electrochemotherapy sessions, six months apart, with intralesional cisplatin (0.25 mL/cm3) and VetCP 125TM electroporator. Side effects were minimal. Because of tumor relapse, onset of joint disorders, and poor prognosis, the animal was euthanized and submitted to necropsy, followed by histopathological and immunohistochemical analyses. Electrochemotherapy significantly improved the tapiŕs life quality. Tumor bleeding resolved, and food uptake was improved. Necropsy demonstrated tumor invasion in adjacent soft tissues and bones and submandibular lymph nodes with multiple areas of metastasis. Overall survival time of 35 months was achieved, with good life quality. Histopathologic characteristics were more aggressive in the relapsed tumor.

Rúbia M. C. Cunha, Gleidice E. Lavalle, Roberto B. Araújo, Herlandes P. Tinoco, Carlyle M. Coelho, Fabíola de Oliveira Paes Leme, Anelise C. Nepomuceno, Luiz A. Lago, Daniel O. Santos, Renato L. Santos, and Marcelo P. N. de Carvalho "ELECTROCHEMOTHERAPY WITH CISPLATIN FOR THE TREATMENT OF A NON-OPERABLE ORAL SQUAMOUS CELL CARCINOMA IN A LOWLAND TAPIR (TAPIRUS TERRESTRIS)," Journal of Zoo and Wildlife Medicine 56(1), 193-198, (10 March 2025). https://doi.org/10.1638/2023-0132
Accepted: 11 December 2024; Published: 10 March 2025
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top